Clinical Trials Browser

Phase 1 × Withdrawn × 3-ingenyl angelate × Clear all

NCT00546611 2016-01-28

The Purpose of This Study is to Determine Whether Topical Application of PEP005 is Safe for the Treatment of Common Wart(s)

Phase 1 Withdrawn

Warts